Both in Pharmaceuticals
Johnson & Johnson vs Merck & Co.
Over the past year JNJ returned +49.7% and MRK returned +89.2%; their daily moves had a correlation of 0.48.
JNJ +49.7% MRK +89.2%Growth of $1, one year, split-adjusted
| Metric | JNJ | MRK |
|---|---|---|
| Price | $271.95 | $148.69 |
| Market cap | $655.37B | $366.84B |
| Today | +0.27% | −0.06% |
| 1 month | +2.3% | −0.6% |
| 6 months | +13.1% | +24.3% |
| Year to date | +31.4% | +41.3% |
| 1 year | +53.0% | +91.6% |
| Revenue growth (YoY) | +6.6% | +5.1% |
| Gross margin | 68.2% | 73.5% |
| Net margin | 21.9% | −8.0% |
| P/E (TTM) | 31.2× | 115.6× |
| Price / sales | 6.7× | 5.5× |
| Net cash | -$28.28B | -$46.77B |
| Dividend yield | 1.97% | 2.29% |
| Volatility (60d) | 20.7% | 33.5% |
| Short % of float | 0.9% | 1.4% |
| Next earnings | Oct 13, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).